Steps taken towards making anti-obesity drug available for public patients

a landmark assessment shows the anti-obesity drug, Wegovy is a safe and effective means of treating patients, that is also cost effective. Clinical Director of the National Centre for Pharmacoeconomics, Michael Barry has more details.

See omnystudio.com/listener for privacy information.